Not so much for either treatment or prevention of mania
J Pharm Investig 48:431441 Kim J, Choi J, Kang H, Ahn J, Hutchings J, Van Niekerk C, Park D, Kim J, Jeon Y, Nam K, Shin S, Shin BS (2022) Safety, tolerability, and pharmacokinetics of Telacebec (Q203), a new antituberculosis agent, in healthy subjects
The drugs are changing the way people eat, and the food industry is taking note
It makes the reward associated with eating feel less compelling
Marston oversees both Ozempic MDLs The consolidated Ozempic lawsuits are pending in the Eastern District of Pennsylvania Ozempic is primarily prescribed for Type 2 diabetes management Some doctors prescribe Ozempic off-label for weight loss Trials in MDLs are scheduled for late 2026 and early 2027, but these dates may change
Those who are overweight or obese and take these medications face a sevenfold increase in risk